The publisher studied Korean history in Seoul and management of business administration in the United Kingdom. He has 20-year experiences in the media business. Kim can be reached at voc200@gmail.com or 82-2-6956-6698.
Yuflyma strives to tap into the U.S. market
South Korean pharmaceutical company Celltrion said on May 25 that its Humira biosimilar CT-P17, or Yuflyma, had...